Natalia A. Rubtsova

Natalia A. Rubtsova

Auto-generated profile, based on publicly available information

Natalia A. Rubtsova

P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2020 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
AKAndrei Kaprin
Andrei Kaprin
EGE. V. Gameeva
E. V. Gameeva
APA. A. Polyakov
A. A. Polyakov
AKA. L. Kornietskaya
A. L. Kornietskaya
NRN. A. Rubtsova
N. A. Rubtsova
AFA. A. Fedenko
A. A. Fedenko
Detailed, systematic review of the world literature data, including all aspects that reflect the impact of the COVID-19 pandemic on the oncological practice was conducted. The information sources were taken from Pubmed, MedLine, Scopus, Web of Science, and RSCI systems. The data from retrospective and prospective clinical trials have been analyzed. This review presents current data on the impact of COVID-19 on cancer patients, mortality and prognosis of cancer patients infected with COVID-19, treatment options for COVID-19, as well as the case report of the cancer patient with rare atypical COVID-19 course of disease. To date, the groups of increased risk of being infected with a new coronavirus have been identified. These groups include cancer patients. Despite the pandemic, treatment of cancer patients must be continued, since the presence of a tumor process does not allow the therapy to be delayed. The world cancer community is actively continuing to develop recommendations for optimal management of cancer patients in the context of the pandemic. The most relevant of them are described in this article.

7 April 2023 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
ECEvgeny L. Choynzonov
Evgeny L. Choynzonov
IRI. V. Reshetov
I. V. Reshetov
SIS. A. Ivanov
S. A. Ivanov
APA. P. Polyakov
A. P. Polyakov
MKM. A. Kropotov
M. A. Kropotov
EKE. V. Kostromina
E. V. Kostromina
The article presents a draft of clinical recommendations for the diagnosis and treatment of differentiated thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.

22 October 2024 in Primary Health Care (Russian Federation)
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
AKAndrei Kaprin
Andrei Kaprin
IAI. I. Almazova
I. I. Almazova
LDL. Yu. Drozdova
L. Yu. Drozdova
EIE. S. Ivanova
E. S. Ivanova
ЖХЖ. В. Хайлова
Ж. В. Хайлова
The Guidelines contain information on the theoretical foundations of screening for malignant neoplasms of the breast, regulatory legal acts regulating the organization of screening activities within the framework of medical examination of certain groups of the adult population, diagnostic algorithms and routing of the examined persons. Guidelines have been developed for the heads of medical organizations providing primary health care in terms of organizing processes, internists, general practitioners, medical workers from among the secondary medical personnel who are directly involved in the implementation of the process of medical examination of certain groups of the adult population.

7 April 2023 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
NSN. V. Severskaya
N. V. Severskaya
ECEvgeny L. Choynzonov
Evgeny L. Choynzonov
IRI. V. Reshetov
I. V. Reshetov
SIS. A. Ivanov
S. A. Ivanov
APA. P. Polyakov
A. P. Polyakov
EKE. V. Kostromina
E. V. Kostromina
The article presents a draft of clinical recommendations for the diagnosis and treatment of medullary thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.

30 June 2020 in Cancer Urology
Verified
Journal Article
Open access
PDF file
NRN. A. Rubtsova
N. A. Rubtsova
AMA. V. Mishchenko
A. V. Mishchenko
VDV. V. Danilov
V. V. Danilov
GGG. A. Gulin
G. A. Gulin
BAB. Ya. Alekseev
B. Ya. Alekseev
AKAndrei Kaprin
Andrei Kaprin
Previously presented Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) system was developed on the basis of consensus that was achieved by the results of published studies containing expert and analytical conclusions. Numerous studies on PI-RADS v2, not only confirmed the importance of a unified system in the diagnosis of prostate cancer, but also revealed a number of limitations. In order to eliminate flaws of PI-RADS v2, a number of potential solutions were proposed. The PI-RADS Steering Committee recommended changes in PI-RADS v2, with maintaining the structure of sequence scoring and using these scores to obtain the final category. The updated version was published as PI-RADS v2.1 at the beginning of 2019. It is expected that the use of PI-RADS v2.1 will optimize and simplify the evaluation magnetic resonance imaging of prostate and reduce the number of interpretation errors. At the same time, it is necessary to continue further studies on the assessment of the clinical significance of this system when choosing a treatment strategy and monitoring patients with a high potentialfor the development

1 October 2025 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
DKDmitry Kabanov
Dmitry Kabanov
NRNatalia Rubtsova
Natalia Rubtsova
AGAleksandra Golbits
Aleksandra Golbits
AKAndrei Kaprin
Andrei Kaprin
Valentin SinitsynValentin Sinitsyn
Valentin Sinitsyn
MPMikhail Potievskiy
Mikhail Potievskiy
Accurate preoperative staging of bladder cancer on MRI remains challenging because visual reads vary across observers. We investigated a multiparametric MRI (mpMRI) radiomics approach to predict muscle invasion (≥T2) and prospectively tested it on a validation cohort. Eighty-four patients with urothelial carcinoma underwent 1.5-T mpMRI per VI-RADS (T2-weighted imaging and DWI-derived ADC maps). Two blinded radiologists performed 3D tumor segmentation; 37 features per sequence were extracted (LifeX) using absolute resampling. In the training cohort (n = 40), features that differed between non-muscle-invasive and muscle-invasive tumors (Mann–Whitney p < 0.05) underwent ROC analysis with cut-offs defined by the Youden index. A compact descriptor combining GLRLM-LRLGE from T2 and GLRLM-SRLGE from ADC was then fixed and applied without re-selection to a prospective validation cohort (n = 44). Histopathology within 6 weeks—TURBT or cystectomy—served as the reference. Eleven T2-based and fifteen ADC-based features pointed to invasion; DWI texture features were not informative. The descriptor yielded AUCs of 0.934 (training) and 0.871 (validation) with 85.7% sensitivity and 96.2% specificity in validation. Collectively, these findings indicate that combined T2/ADC radiomics can provide high diagnostic accuracy and may serve as a useful decision support tool, after multicenter, multi-vendor validation.